35295-5
BTK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Active
Part Descriptions
LP227842-4 BTK gene targeted mutation analysis
Bruton's tyrosine kinase (BTK) plays a crucial role in oncogenic signaling that is critical for proliferation and survival of leukemic cells in many B cell malignancies. BTK was initially shown to be defective in the primary immunodeficiency X-linked agammaglobulinemia (XLA) and B cell development and the function of mature B cells. The orally administered irreversible BTK inhibitor ibrutinib is associated with high response rates in patients with relapsed/refractory chronic lymphocytic leukemia (CLL). PMID: 29455639
Source: NCBI PubMed
LP33144-4 BTK gene
The BTK gene (Bruton agammaglobulinemia tyrosine kinase) [HGNC Gene ID:1133] is located on chromosome Xq21.33-q22. The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013] [NCBI Gene ID:695]
Source: National Center for Biotechnology Information (NCBI) Gene
LP33144-4 BTK gene
Patients with chronic lymphocytic leukemia (CLL) with disease progression treated with ibrutinib has been attributed to histologic transformation or acquired mutations in BTK and PLCG2 genes. PMID: 28049639
Source: PubMed Central
Fully-Specified Name
- Component
- BTK gene targeted mutation analysis
- Property
- Prid
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Nom
- Method
- Molgen
Additional Names
- Short Name
- BTK gene Mut Anl Bld/T
- Display Name
- BTK gene targeted mutation analysis Molgen Nom (Bld/Tiss)
- Consumer Name Alpha Get Info
- BTK gene targeted mutation analysis, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.MUT
- Type
- Laboratory
- First Released
- Version 2.13
- Last Updated
- Version 2.73
- Change Reason
- Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 11573
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Gen BTK Analisis de mutaciones: |
es-AR | Spanish (Argentina) | gen BTK: |
es-MX | Spanish (Mexico) | Análisis de mutaciones dirigidas al gen BTK: |
fr-FR | French (France) | BTK gène mutation cible trouvée: |
it-IT | Italian (Italy) | BTK, gene analisi di mutazione mirata: Synonyms: Gene BTK Genetica molecolare Mutazione genica Patologia molecolare Presenza o Identità Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
ko-KR | Korean (Korea, Republic Of) | BTK 유전자 돌연변이 분석: |
nl-NL | Dutch (Netherlands) | BTK-gen doelgerichte mutatie-analyse: Synonyms: BTK gen molgen targeted |
pt-BR | Portuguese (Brazil) | BTK análise de mutação genética: Synonyms: AGMX1; |
ru-RU | Russian (Russian Federation) | BTK ген исследование на мутацию: Synonyms: Кровь Кровь или Ткань Номинальный; |
tr-TR | Turkish (Turkey) | BTK geni Mutasyon analizi: |
zh-CN | Chinese (China) | BTK 基因 突变分析: Synonyms: AGMX1; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=35295-5
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright